A monoclonal antibody based ELISA for quantitation of human leukaemia inhibitory factor

Cytokine

Volumn 9, Issue 2, 1997, Pages 112-118

  Taupin, Jean Luc ^a   Gualde, Norbert ^a   Moreau, Jean François ^a  

^a CNRS Bordeaux Segalen University   (France)

Author keywords

ELISA; Leukaemia inhibitory factor; Monoclonal antibodies

Indexed keywords

CYTOKINE; LEUKEMIA INHIBITORY FACTOR; MONOCLONAL ANTIBODY;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; QUANTITATIVE ASSAY;

EID: 0031081744     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0144     Document Type: Article

References (28)

1. 1. Moreau JF, Bonneville M, Godard A, Gascan H, Gruart V, Moore MA, Soulillou JP (1987) Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burst-promoting activities. J Immunol 138:3844-3849.
2. 2. Anegon I, Moreau JF, Godard A, Jacques Y, Peyrat MA, Hallet MM, Wong G, Soulillou JP (1990) Production of HILDA/LIF by activated monocytes. Cell Immunol 130:50-65.
3. 3. Metcalf D (1991) The leukemia inhibitory factor (LIF). Int J Cell Cloning 9:95-108.
4. 4. Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau JF, Stahl M, Rogers D (1988) Inhibition of pluripotential embryonic stem cells differentiation by purified polypeptides. Nature 336: 688-690.
5. 5. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM (1988) Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336:684-687.
6. 6. Baumann H, Wong GG (1989) Hepatocyte stimulating factor III shares structural and functional identity with leukemia inhibitory factor. J Immunol 143:1163-1167.
7. 7. Metcalf D, Hilton D, Nicola NA (1991) LIF can potentiate murine megakaryocyte production in vitro. Blood 77:2150-2153.
8. 8. Abe E, Tanaka H, Ishimi Y, Miyaura C, Hayashi T, Nagasawa H, Tomida M, Yamaguchi Y, Hozumi M, Suda T (1986) Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci USA 83:5958-5962.
9. 9. Reid IR, Lowe C, Cornish J, Skinner SJM, Hilton DJ, Willson TA, Gearing DP, Martin TJ (1990) LIF: a novel bone-active cytokine. Endocrinology 126:1416-1420.
10. 10. Metcalf D, Gearing DP (1989) A myelosclerotic syndrome in mice with cells producing high levels of LIF. Leukemia 3:847-852.
11. 11. Metcalf D, Gearing DP (1989) Fatal syndrome in mice engrafted with cells producing high levels of LIF. Proc Natl Acad Sci USA 86:5948-5952.
12. 12. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbodanjo SJ (1992) Blastocyst implantation depends on maternal expression of LIF. Nature 359:76-79.
13. 13. Moreau JF, Bonneville M, Godard A, Gascan H, Gruart V, Moore MAS, Soulillou JP (1987) Characterisation of a factor produced by human T-cell clones exhibiting eosinophil activating and burst promoting activities. J Immunol 138:3844-3849.
14. 14. Waring PM, Wycherley K, Cary D, Nicola NA, Metcalf D (1992) Leukemia inhibitory factor levels in septic shock and various inflammatory body fluids. J Clin Invest 90:2031-2037.
15. 15. Taupin JL, Morel D, Moreau JF, Gualde N, Potaux L, Bezian JH (1992) LIF/HILDA urinary excretion during acute kidney rejection. Transplantation 53:655-658.
16. 16. Blancho G, Moreau JF, Anegon I, Soulillou JP (1992) HILDA/LIF is present in the urine of rejecting kidney graft recipients. Transpl Int 5:57-58.
17. 17. Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D (1993) Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritis. Arthritis Rheum 36:911-915.
18. 18. Waring PM, Romero R, Laham N, Gomez R, Rice GE (1994) Leukemia inhibitory factor: association with intraamniotic infection. Am J Obstet Gynecol 171:1335-1341.
19. 19. Waring PM, Waring LJ, Metcalf D (1994) Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia. J Infectious Diseases 170:1224-1228.
20. 20. Mire-Sluis A, Page L, Thorpe R (1995) Quantitative cell line based bioassays for human cytokines. J Immunol Methods 187:191-199.
21. 21. Taupin JL, Acres B, Dott K, Schmitt D, Kieny MP, Gualde N, Moreau JF (1993) Immunogenicity of HILDA/LIF either in a soluble or a membrane anchored form expressed in vivo by recombinant vaccinia viruses. Scand J Immunol 38:293-301.
22. 22. Moreau JF, Donaldson DD, Bennett F, Witek-Giannotti JA, Clark SC, Wong GG (1988) Leukemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 336:690-692.
23. 23. Gascan H, Godard A, Ferenz C, Naulet J, Praloran V, Peyrat MA, Jacques Y, Moreau JF, Soulillou JP (1989) Characterisation and NH2-terminal amino acid sequence of natural LIF/HILDA/DIA secreted by a T lymphoma cell line. J Biol Chem 264:21509-21515.
24. 24. Layton MJ, Cross BA, Metcalf D, Ward LD, Simpson RJ, Nicola NA (1992) A major binding protein for leukemia inhibitory factor in normal mouse serum - identification as a soluble form of the cellular receptor. Proc Natl Acad Sci USA 89:8616-8620.
25. 25. Williams RL, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM (1988) Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336:684-687.
26. 26. Gearing DP, Nicola NA, Metcalf D, Foote S, Willson TA, Gough NM, Williams RL (1989) Production of leukemia inhibitory factor in E. coli by a novel procedure and its use in maintaining embryonic stem cells in culture. Biotechnology 7:1157-1161.
27. 27. Ledur A, Fitting C, David B, Hamberger C, Cavaillon JM (1995) Variable estimates of cytokine levels produced by commercial ELISA kits - improved results using international cytokine standards. J Immunol Methods 186:171-179.
28. 28. Mire-Sluis AR, Gaines-Das R, Thorpe R (1995) Immunoassays for detecting cytokines: what are they really measuring? J Immunol Methods 186:157-160.